Abstract:Objective: Cancer is a complex genetic disease characterized by the accumulation of various mutations, with driver genes playing a crucial role in cancer initiation and progression. Distinguishing driver genes from passenger mutations is essential for understanding cancer biology and discovering therapeutic targets. However, the majority of existing methods ignore the mutational heterogeneity and commonalities among patients, which hinders the identification of driver genes more effectively. Methods: This study introduces MCSdriver, a novel computational model that integrates network and pathway information to prioritize the identification of cancer driver genes. MCSdriver employs a bidirectional random walk algorithm to quantify the mutual exclusivity and functional relationships between mutated genes within patient cohorts. It calculates similarity scores based on a mutual exclusivity-weighted network and pathway coverage patterns, accounting for patient-specific heterogeneity and molecular profile similarity. Results: This approach enhances the accuracy and quality of driver gene identification. MCSdriver demonstrates superior performance in identifying cancer driver genes across four cancer types from The Cancer Genome Atlas, showing a higher F-score, Recall and Precision compared to existing ranking list-based and module-based models. Conclusion: The MCSdriver model not only outperforms other models in identifying known cancer driver genes but also effectively identifies novel driver genes involved in cancer-related biological processes. The model's consideration of patient-specific heterogeneity and similarity in molecular profiles significantly enhances the accuracy and quality of driver gene identification. Validation through Gene Ontology enrichment analysis and literature mining further underscores its potential application value in personalized cancer therapy, offering a promising tool for advancing our understanding and treatment of cancer.

Discovering Driver Mutation Profiles in Cancer with a Local Centrality Score.

Identification of Driver Genes Based on Gene Mutational Effects and Network Centrality

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Identification of Cancer Driver Modules by Combining Network Functional and Topology Information.

Discovering Potential Cancer Driver Genes by an Integrated Network-Based Approach.

DriverML: a Machine Learning Algorithm for Identifying Driver Genes in Cancer Sequencing Studies

Identification of Driver Network Modules in Protein-Protein Interaction Network Using Patient Mutation Profiles

A Random Walk-Based Method to Identify Driver Genes by Integrating the Subcellular Localization and Variation Frequency into Bipartite Graph

Detection Of Driver Pathways Using Mutated Gene Network In Cancer

Discovering potential driver genes through an integrated model of somatic mutation profiles and gene functional information.

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Advancing cancer driver gene identification through an integrative network and pathway approach

MECoRank: Cancer Driver Genes Discovery Simultaneously Evaluating the Impact of SNVs and Differential Expression on Transcriptional Networks.

DriverFinder: A Gene Length-Based Network Method to Identify Cancer Driver Genes

Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer

DriverMP enables improved identification of cancer driver genes

DriverRWH: Discovering Cancer Driver Genes by Random Walk on a Gene Mutation Hypergraph

Identifying Key Genes in Cancer Networks Using Persistent Homology

PathDriver: Cancer Driver Genes Identification Based on the Metabolic Pathway

Cancer Core Modules Identification Through Genomic and Transcriptomic Changes Correlation Detection at Network Level.

Detection of Driver Modules with Rarely Mutated Genes in Cancers